作者：
Sujan,Piya [1]
;
Yaling,Yang [2]
;
Seemana,Bhattacharya [3]
;
Priyanka,Sharma [3]
;
Huaxian,Ma [3]
;
Hong,Mu [3]
;
Hua,He [2]
;
Vivian,Ruvolo [3]
;
Natalia,Baran [3]
;
R Eric,Davis [4]
;
Abhinav K,Jain [5]
;
Marina,Konopleava [3]
;
Hagop,Kantarjian [3]
;
Michael,Andreeff [3]
;
M James,You [6]
;
Gautam,Borthakur [7]
作者单位：
Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. SPiya@mdanderson.org.
[1]
Department of Hematopathology, Unit 72, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
[2]
Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
[3]
Department of Lymphoma/Myeloma, Unit 903, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
[4]
Department of Epigenetics & Molecular Carcinogenesis, Center for Cancer Epigenetics, Unit 1000, The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.
[5]
Department of Hematopathology, Unit 72, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. mjamesyou@mdanderson.org.
[6]
Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. GBorthak@mdanderson.org.
[7]
DOI
10.1038/s41375-022-01516-1
PMID
35173274
发布时间
2024-12-04
换一批
换一批
